We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ED:NYSEConsolidated Edison, Inc. Analysis

Data as of 2026-03-30 - not real-time

$113.33

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Consolidated Edison (ED) is trading at $113.33, comfortably above its 20‑day ($112.06), 50‑day ($109.87) and 200‑day ($102.38) moving averages, indicating a short‑term bullish momentum. The RSI sits at 58, suggesting room for further upside, yet the MACD histogram is negative and the signal line is bearish, warning of a possible near‑term pullback. A DCF‑derived fair value of $106.31 places the stock roughly 7% above intrinsic value, and the upside/downside metric is –2.2%, implying the market may be pricing in optimism beyond fundamentals. Revenue growth remains healthy at 9% YoY with a solid gross margin of 53% and operating margin of 18%, but free cash flow is slightly negative and debt‑to‑equity is high at 117%, flagging balance‑sheet pressure. Dividend sustainability looks reassuring: a 3.08% yield, a 60% payout ratio, and a recent board decision to raise the dividend to $0.8875 per share underscore the company’s commitment to income investors. Recent analyst notes from JPMorgan and Morgan Stanley lifted price targets modestly to $113 and $106 respectively, yet both retain a cautious stance, reflecting the mixed valuation signals. Overall, the stock offers a blend of defensive utility exposure and attractive yield, but investors should weigh the modest overvaluation and leverage against the regulated cash‑flow stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance level of $116.23
  • Bearish MACD signal despite bullish trend
  • Strong dividend yield supporting demand

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable regulated revenue and 9% growth
  • High debt load requiring monitoring
  • Consistent dividend payments

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and defensive utility profile
  • Attractive dividend yield and payout growth
  • Regulated cash‑flow resilience over economic cycles

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin11.96%
P/E Ratio20.1
ROE8.77%
ROA3.19%
Debt/Equity117.32
P/B Ratio1.7
Op. Cash Flow$4.8B
Free Cash Flow$-145250000
Industry P/E22.9

Technical Analysis

TrendBullish
RSI57.9
Support$108.48
Resistance$116.23
MA 20$112.06
MA 50$109.87
MA 200$102.38
MACDBearish
VolumeDecreasing
Fear & Greed Index67.77

Valuation

Fair Value$106.31
Target Price$110.88
Upside/Downside-2.16%
GradeOvervalued
TypeValue
Dividend Yield3.08%

Risk Assessment

Beta-0.17
Volatility18.26%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.